Who depends on Biomedical Advanced Research And Development Authority
Biomedical Advanced Research And Development Authority appears in 1 disclosed customer relationships between 2017 and 2023.
Get an email when Biomedical Advanced Research And Development Authority's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on Biomedical Advanced Research And Development Authority
Listed companies whose annual report names Biomedical Advanced Research And Development Authority as a customer worth 10% or more of their revenue. If Biomedical Advanced Research And Development Authority cuts orders or switches supplier, these are the companies that feel it.
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| ModernaMRNA | 65% | last FY 2020 | 3 years | FY 2020 · filed 24 Feb 2023 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API